Clearstead Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.7K Buy
+864
New +$27.4K ﹤0.01% 1738
2024
Q3
Sell
-181
Closed -$5.37K 2101
2024
Q2
$5.37K Buy
181
+132
+269% +$3.66K ﹤0.01% 1677
2024
Q1
$1.3K Hold
49
﹤0.01% 1376
2023
Q4
$1.4K Sell
49
-2,185
-98% -$64.2K ﹤0.01% 1347
2023
Q3
$82.8K Hold
2,234
0.01% 593
2023
Q2
$87.1K Buy
+2,234
New +$87.5K 0.01% 608

Other funds holding RTO

Clearstead Advisors's RTO Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Rentokil (RTO) in Q2 2026: 864 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #1738 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in RTO as recently as Q2 2024.

Clearstead Advisors first reported a position in RTO in Q2 2023 and has held it in 6 quarters since. The position peaked at $87.1K in Q2 2023. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Clearstead Advisors held 864 shares of Rentokil worth $24.7K as of Q2 2026.
  • Rentokil was a new Clearstead Advisors position in Q2 2026.
  • Rentokil made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1738 holding.
  • Clearstead Advisors first reported a position in Rentokil in Q2 2023 and has held it in 6 quarters since.
  • Clearstead Advisors's Rentokil position peaked at $87.1K in Q2 2023.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.